References
- Skinner MW, Nugent D, Wilton P, et al., Achieving the unimaginable: health equity in haemophilia. Haemophilia. 2020. 26(1): 17–24.
- World Health Organization. Health equity [cited 2021 Aug 2]. Available from: https://www.who.int/westernpacific/health-topics/equity.
- Lopez K, Norris K, Hardy M, et al. Defining the impact of social drivers on health outcomes for people with inherited bleeding disorders. J Clin Med. 2022;11:15.
- National Hemophilia Foundation. Mission & history [cited 2022 Jan 5]. Available from: https://www.hemophilia.org/who-we-are/our-story/mission-history.
- Valentino LA, Witkop ML, Santaella ME, et al., Building the blueprint: formulating a community-generated national plan for future research in inherited bleeding disorders. Haemophilia. 2022. 28(5): 760–768.
- American Thrombosis and Hemostasis Network. Why conduct your research sudy with ATHN [cited 2023 Jan 4]. Available from: https://www.athn.org/what-we-do/for-researchers/why-conduct-your-research-study-with-athn.html.
- Tran DQ, Benson CC, Boice JA, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. Expert Rev Hematol. 2023;16(S1):19–37. DOI: 10.1080/17474086.2023.2171981.
- Sidonio RF Jr., Bryant PC, Di Paola J, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders. Expert Rev Hematol. 2023;16(S1):39–54. DOI: 10.1080/17474086.2023.2171983.
- Nugent D, Acharya SS, Baumann KJ, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders. Expert Rev Hematol. 2023;16(S1):55–70. DOI: 10.1080/17474086.2023.2175661.
- Baldwin MK, Ahmadzia HK, Bartlett DL, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate. Expert Rev Hematol. 2023;16(S1):71–86. DOI: 10.1080/17474086.2023.2175660.
- Byams VR, Baker JR, Bailey C, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science. Expert Rev Hematol. 2023;16(S1):87–107. DOI: 10.1080/17474086.2023.2183836.
- Ragni MV, Young G, Batsuli G, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding. Expert Rev Hematol. 2023;16(S1):107–127. DOI: 10.1080/17474086.2023.2181781.
- Centers for Disease Control and Prevention. HTC population profile patient characteristics march 2022 - technical notes 2022 [cited 2022 Nov 4]. Available from: https://www.cdc.gov/ncbddd/hemophilia/communitycounts/data-reports/2022-03/index.html.
- USA Facts. How has the population changed in the US? [cited 2023 Jan 4]. Available from: https://usafacts.org/data/topics/people-society/population-and-demographics/our-changing-population?endDate=2021-01-01&startDate=2020-01-01.
- Peyvandi F, Miri S, Garagiola I. Immune responses to plasma-derived versus recombinant FVIII products. Front Immunol. 2020;11:591878.
- Arya S, Wilton P, Page D, et al. Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders. PLoS One. 2020;15(2):e0229099.
- van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH. J Thromb Haemost. 2021;19(8):1883–1887.
- Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost. 2021;5(1):51–54.
- Weyand AC, McGann PT. Eliminating race-based reference ranges in haematology: a call to action. Lancet Haematol. 2021;8(6):e462–e6.
- Skinner MW, Soucie JM, McLaughlin K. The national haemophilia program standards, evaluation and oversight systems in the United States of America. Blood Transfus. 2014;12 Suppl 3(Suppl3):e542–8.
- National Hemophilia Foundation. Federal Programs [cited 2023 Jan 4]. Available from: https://www.hemophilia.org/advocacy/federal-priorities/federal-programs.
- Baker JR, Crudder SO, Riske B, et al. A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders. Am J Public Health. 2005;95(11):1910–1916.
- Valentino L, Baker J, Butler R, et al. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med. 2021;12:897–911.
- Vázquez E, Kim M, Santaella ME. Lived experience experts: a name created by us for us. Expert Rev Hematol. 2023;16(S1):7–11. DOI: 10.1080/17474086.2023.2178410.
- Valentino LA, Witkop ML, Santaella ME, et al. The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders. Expert Rev Hematol. 2023;16(S1):1–5. DOI: 10.1080/17474086.2023.2178412.
- World Federation of Hemophilia.World Federation of Hemophilia report on the annual global survey 2021. WFH:Montréal Canada 2022. [cited 2023 Jan 29]. Available from. https://www1.wfh.org/publications/files/pdf-2324.pdf
- Witkop ML, Robinson F, DiMichele D. Soliciting international perspectives on an American national research agenda for inherited bleeding disorders, Exp Rev Hem, 2023;16(S1):13–17. DOI: 10.1080/17474086.2023.2178411.